Newron Pharmaceuticals secures EUR 5.5 million through an investor group as part of up to EUR 38 million financing to support the ENIGMA-TRS Phase 3 program.
Amount Raised
€5.5 Million
Round Type
Venture
Description
Newron Pharmaceuticals announced an investment of EUR 5.5 million from an investor group as part of a larger EUR 38 million financing. This funding will strengthen the company's financial position as it advances its ENIGMA-TRS Phase 3 program. The investor group initially subscribed to a total of EUR 15 million and is expected to contribute more in the future. The new shares will be listed on multiple exchanges starting today.
Quick answer
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised €5.5 Million in a funding round, dated September 8, 2026. Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy.
- How much did Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raise?
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised €5.5 Million in a funding round on September 8, 2026.
- What does Newron Pharmaceuticals S.p.A. & EA Pharma Ltd do?
- Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.
- Where is Newron Pharmaceuticals S.p.A. & EA Pharma Ltd based and how big is it?
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy. Fundz records about 23 employees.
- Who are the decision-makers at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd?
- Fundz holds 3 contacts at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, including the Chief Financial Officer, IAB Member. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Newron Pharmaceuticals S.p.A. & EA Pharma Ltd that raised within 45 days of this round, from Fundz verified event records.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
Who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, and when
A new round usually means Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.